Литература. 
Профилактика венозной тромбоэмболии у пациентов на госпитальном этапе

1. Hirsch D.R., Ingenito E.P., Goldhaber S.Z. Prevalence of deep venous thrombosis among patients in medical intensive care // JAMA. — 1995. — 274. — 335−337.

2. Goldhaber S.Z., Dunn K., MacDougall R.C. New onset of venous thromboembolism among hospitalized patients at Brigham and Women’s Hospital is caused more often by prophylaxis failure than by withholding treatment // Chest. — 2000. — 118. — 1680−1684.

3. Goldhaber S.Z., Tapson V.F., DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis // Am. J. Cardiol. — 2004. — 93. — 259−262.

4. Comerota A.J., Chouhan V., Harada R.N., Sun L., Hosking J., Veermansunemi R., Comerota A.J. Jr, Schlappy D., Rao A.K. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis // Ann. Surg. — 1997. — 226. — 306−314.

5. Kessler C.M., Hirsch D.R., Jacobs H., MacDougall R., Goldhaber S.Z. Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation // Blood Coagul. Fibrinolysis. — 1996. — 7. — 437−446.

6. Samama M.M., Cohen A.T., Darmon J.Y., Desjardins L., Eldor A., Janbon C., Leizorovicz A., Nguyen H., Olsson C.G., Turpie A.G., Weisslinger N. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group // N. Engl. J. Med. — 1999. — 341. — 793−800.

7. Leizorovicz A., Cohen A.T., Turpie A.G., Olsson C.G., Vaitkus P.T., Goldhaber S.Z. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients // Circulation. — 2004. — 110. — 874−879.

8. Cohen A.T., Gallus A.S., Lassen M.R., Tomkowski W., Turpie A.G.G., Davidson B.L., Cariou R.G., Lensing A.W.A., Egberts J.F.M. Fondaparinux vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients (ARTEMIS) // J. Thromb. Haemost. — 2003. — 1 (suppl. 1). — P. 2046. Abstract.

9. Alikhan R., Cohen A.T., Combe S., Samama M.M., Desjardins L., Eldor A., Janbon C., Leizorovicz A., Olsson C.G., Turpie A.G. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study // Arch. Intern. Med. — 2004. — 164. — 963−968.

10. Kleber F.X., Witt C., Vogel G., Koppenhagen K., Schomaker U., Flosbach C.W. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease // Am. Heart. J. — 2003. — 145. — 614−621.

11. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients // BMJ. — 2002. — 324. — 71−86.

12. Kakkar A.K., Davidson B.L., Haas S.K.; The Investigators Against Thromboembolism (INATE) Core Group. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines // J. Thromb. Haemost. — 2004. — 2. — 221−227.

13. Bates D.W., Gawande A.A. Improving safety with information technology // N. Engl. J. Med. — 2003. — 348. — 2526−2534.

14. Dexter P.R., Perkins S., Overhage J.M., Maharry K., Kohler R.B., McDonald C.J. A computerized reminder system to increase the use of preventive care for hospitalized patients // N. Engl. J. Med. — 2001. — 345. — 965−970.

15. Geerts W.H., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., Ray J.G. Prevention of venous thromboembolism // Chest. — 2004. — 126. — 338S-400S.